About the project
Prostate cancer is the most common type of cancer in men and their second leading cause of death; however, it is highly treatable in the early stages. Recent studies and clinical trials have demonstrated the efficiency of prostate MRI in early diagnosis, with 5 times less missed cancer cases and 25 % fewer biopsies.
Care standards now recommend MRI prior to every biopsy, leading to an increased demand for prostate MRI scans. Conventional radiology reading capacity cannot keep pace with the demand.
At Quantib, we developed an AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists.The current EU-funded ID-PROSTATE project allows further improvement and acceleration focusing on product commercialization.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 961205.